About Us

Archives






Morphic Therapeutic to Host Analyst and Investor Call on July 9, 2021

Posted: July 5, 2021 at 1:51 am


Call to discuss positive results from Phase 1 trial of MORF-057 to be presented at ECCO 2021 Virtual Congress Call to discuss positive results from Phase 1 trial of MORF-057 to be presented at ECCO 2021 Virtual Congress

More here:
Morphic Therapeutic to Host Analyst and Investor Call on July 9, 2021

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.